Explanatory Factors and Predictors of Fatigue in Patients With Sjögren's Disease: A 3-month Longitudinal Study
NCT07544394 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-04-27
Summary
This prospective longitudinal study will be conducted in patients diagnosed with Sjögren's disease who are followed at the rheumatology outpatient clinic of Kahramanmaras Sutcu Imam University Medical Faculty Hospital. Demographic and clinical data will be collected from routine clinical assessments and medical records, including laboratory results obtained during standard care.
Participants will undergo evaluation of pressure pain threshold using a digital algometer and complete validated questionnaires assessing fatigue, disease activity, patient-reported symptoms, anxiety and depression, pain catastrophizing, sleep quality, and physical activity level.
All assessments will be performed at baseline and repeated at follow-up visits approximately 3 months later.
Conditions
- Sjogren's Disease
- Fatigue
Sponsors & Collaborators
-
Kahramanmaras Sutcu Imam University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-20
- Primary Completion
- 2027-12-30
- Completion
- 2028-04-20
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Salivary Biomarkers for Sjögren's Syndrome Detection
NCT01807689 ·Status: COMPLETED
-
Prevalence of Pre-clinical Sjögren Disease and Other Immune Disturbances in Subjects With Autoimmune Thyroiditis Disease
NCT06324578 ·Status: RECRUITING
-
The 2019 EULAR/ACR Classification Criteria as Predictor of Organ Damage in Systemic Lupus Erythematosus Patients
NCT06313151 ·Status: RECRUITING
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED
-
Observational Study Investigating Demographic and Clinical Characteristics of SLE Patients in Egypt
NCT07144514 ·Status: NOT_YET_RECRUITING
-
B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome
NCT04931160 ·Status: RECRUITING ·Phase: NA
-
Self-Acupressure on Pain, Fatigue and Sleep Quality in Systemic Lupus Erythematosus
NCT05453422 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Clinical Pilates Training on Fatigue, Emotional State, Functional Capacity, Sleep and Quality of Life in Women With Systemic Lupus Erythematosus
NCT07394361 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
NCT05971498 ·Status: UNKNOWN
-
Systemic Lupus Erythematosus
NCT05984316 ·Status: RECRUITING ·Phase: NA
-
A Study of RSLV-132 in Females With Sjögren's Disease
NCT06440525 ·Status: RECRUITING ·Phase: PHASE2
-
Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome
NCT06862284 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Fatigue, Depression, and Cortical Excitability in Systemic Lupus
NCT03165682 ·Status: UNKNOWN
-
Study of Iguratimod in Sjögren's Syndrome
NCT03023592 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity
NCT06610409 ·Status: NOT_YET_RECRUITING
-
Clinical Characteristics and Outcomes of SLE Patients Admitted to Critical Care Unit
NCT05418855 ·Status: UNKNOWN
-
Tolerance and Efficacy of Rituximab in Sjogren's Disease
NCT00740948 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ro60 Expression in Macrophages in Sjogren's Disease
NCT06324968 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prognostic Factors for Treatment Responses in Patients With Active Lupus Nephritis at Sohag University Hospital
NCT04756492 ·Status: UNKNOWN
-
Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome
NCT00391924 ·Status: COMPLETED ·Phase: PHASE2
-
This Project Aims to Understand the Needs of Rheumatologists and Other Specialties in the Care of Patients With SLE
NCT06698900 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
NCT06104124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome
NCT01008982 ·Status: COMPLETED ·Phase: PHASE2
-
Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases
NCT04530461 ·Status: UNKNOWN
-
Polymyalgia Rheumatica Associated to Primary Sjogren Syndrome
NCT05312944 ·Status: UNKNOWN